Optimising Informed CONsent in clinical trials in low- and middle-income settings: feasibility of an adapted QuinteT Recruitment Intervention (QRI) in India - OrION-1

Seth GSMC KEM Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年1月9日

试验速览

暂无简介。

•1. Randomised Controlled Trials: Ongoing RCTs in the Department of Clinical Pharmacology that are open to recruitment will be purposively selected for this study, based on whether they a) have sufficient recruitment period remaining and b) regularly screen patients.
•2. Patients: Adults over 18 years of age, who go through the informed consent process in the selected RCTs will be approached for consent to the OrION-I study.
•3. Recruiters: The healthcare professionals and/or other researchers involved in the process of obtaining informed consent from patients will be approached for consent to the OrION-I study.

•1. RCTs where the sponsor denies permission for the RCT to be included in OrION-I.
•2. The potential patient participants or the recruiters in the selected RCTs who decline consent for this study (or where patient is unable to provide consent).

发起方

Seth GSMC KEM Hospital